Home » FDA Strengthens Warning on Glaxo’s Avandia
FDA Strengthens Warning on Glaxo’s Avandia
The U.S. Food and Drug Administration Wednesday toughened warnings on GlaxoSmithKline PLC’s diabetes drug Avandia, saying the product was linked to a potential increase in the risk of heart attacks.
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May